News Roche's COPD candidate fails a phase 3 readout Roche gambled on an all-comer design for trials of its COPD candidate astegolimab, a move that may prove costly as it fails a phase 3 test.
News AI 'could detect laryngeal cancer from patient voices' Researchers in the US have found that subtle changes in the sound of a voice could be used to detect if someone has cancer of the larynx.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
